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DWIAbstract Purpose: To evaluate the role of magnetic resonance spectroscopy & diffusion weighted
imaging (DWI) in differentiating between primary and secondary brain tumors.
Patients & methods: This prospective study was performed for 40 patients. Diffusion weighted
image (DWI) and apparent diffusion co-efficient (ADC) maps were acquired by using b-values of
0 and 1000 mm2/s. Standard mean ADC values were calculated automatically and expressed in
103 mm2/s in both intra-lesional and peri-lesional regions. Multi voxel MR spectroscopy was per-
formed using a spin-echo mode sequence.
The metabolites were identified including the following: N-acetylaspartate (NAA) at 2.0 ppm, cre-
atine (Cr) at 3.0 ppm, choline (Cho) at 3.2 ppm, lipid at the range of 0.7–1.3 ppm, lactate at
1.33 ppm and myoinositol at 3.56 ppm. The ratios that were calculated include the following:
Cho/NAA and Cho/Cr in both intralesional and perilesional regions.
Results: Intralesional ADC values showed no difference between the metastases (0.6:
1  103 mm2/s with mean 0.86) and high grade primary tumors (0.6: 1.1  103 mm2/s with mean
0.73). Perilesional ADC value Findings in the study revealed that primary tumors have low ADC
values (0.9: 1.1  103 mm2/s with mean 0.95) in their peri-lesional voxels denoting peri-lesional
infiltration, while higher ADC values in metastasis (1.3–1.6  103 mm2/s mean 1.41) due to the
absence of peri-lesional infiltration increase in CHO/Cr ratios (>1) in primary high grade tumors
(indicating perilesional infiltration) while there was no increase in CHO/Cr ratio in cases of
metastases. Low grade primary tumors showed low lactate and lipid, with increasing malignancy,
and tumors showed increasing levels of lactate and lipid peaks (indicating necrosis) with remarkable
difference in lipid peaks between low and high grade tumors. There was no significant difference
between primary & metastatic brain tumors as regards lactate peak.wy84@
1038 A.M.N. Darwiesh et al.Conclusion: Intra-lesional ADC values are not useful in the differentiation between primary and
metastatic tumors. Perilesional ADC values can differentiate between primary & metastatic brain
tumors. Intralesional MRS values (CHO/Cr ratio) were able to grade the tumor and differentiate
between high and low grade tumors, while Perilesional MRS values (CHO/Cr ratio) could be able
to differentiate primary tumors from metastasis.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Intracranial tumors are a significant health problem. The
annual incidence of primary and secondary central nervous
system neoplasms ranges from 10 to 17 per 100,000 persons
(1). Brain tumors are subdivided into supra-tentorial & infra-
tentorial brain tumors (2). Differentiation of low grade from
high grade glioma, neoplastic from non-neoplastic brain
masses by using conventional MRI is frequently difficult,
and many cases require biopsy or follow-up imaging. Gadolin-
ium enhancement is useful in evaluation of brain tumors.
Recent MR imaging techniques, such as MR spectroscopy,
can further improve the diagnostic accuracy of MR imaging
in the diagnosis of such tumors (2,3). Magnetic resonance
spectroscopy is a technique that allows the study of some
metabolites in the brain or neoplasms that point to the nature
of these lesions, grading of brain tumors, and follow-up and to
evaluate the response of these lesions to treatment (4). Mag-
netic resonance spectroscopy is an analytical method used to
identify molecules and to determine their biophysical charac-
teristics (5). Thus, this technique is a multi-parametrical molec-
ular imaging method that can complete MRI study enabling
the detection of biochemical patterns of different features
and aspects of brain tumor (6). Diffusion-weighted imaging
(DWI) helps us to obtain additional information about the
brain from the microscopic movement of water molecules.
DWI has been used to detect the nature of brain tumors
according to their cellularity and to differentiate between high
cellular and low cellular brain tumors (7,8).2. Patients and methods
The study protocol was approved by the local Ethics Commit-
tee, and informed consent was obtained from all patients. This
prospective study included 40 patients, and their age ranged
from 30 to 65 years old with suspicious of intra-axial supraten-
torial brain tumors by CT.
2.1. Image protocol
All examinations were performed using a 1.5 T MR Unit
(SIGNA Horizon, General Electric Medical System, Milwau-
kee, WI) using head coil.
2.2. Magnetic resonance spectroscopy (MRS)
Multi voxel MR spectroscopy was performed using a spin-
echo mode sequence (SE) with long TE (144 mm/s) and short
TE (35 mm/s). Water suppression was achieved with chemicalshift selection (CHESS) technique. The voxels were placed on
the lesions and perilesional areas away from CSF and scalp fat
to avoid contamination and voxel was placed in normal
region. The metabolites were identified including the following:
N-acetyl aspartate (NAA) at 2.0 ppm, creatine (Cr) at
3.0 ppm, choline (Cho) at 3.2 ppm, lipid at the range of 0.7–
1.3 ppm, lactate at 1.33 ppm and myoinositol at 3.56 ppm.
The ratios were calculated including the following: Cho/
NAA and Cho/Cr in both intralesional and perilesional
regions.
2.3. Diffusion weighted imaging with apparent diffusion
coefficient calculation
DW images were obtained by using an axial echo-planar SE
sequence, average, 5 mm section thickness. DW images and
ADC maps were acquired by using b values of 0 and 1000 s/
mm2. Post processing of ADC maps was performed. Standard
mean ADC values were calculated automatically and
expressed in 103 mm2/s.
2.4. Statistical analysis
Statistical analysis was undertaken to prove the efficacy of
MRS & diffusion in the evaluation of supratentorial brain
tumors. Statistical analysis was performed using the SPSS soft-
ware package version 16.0 (statistical package for social
science TM) and P< 0.05 was considered to be statistically
significant. The sensitivity and specificity for each protocol
were compared in order to evaluate the reliability of each of
them and when they are combined.
3. Results
In this prospective study, forty patients were included in this
study with supra-tentorial brain tumors. Their age ranged
from 30 to 65 years old.
3.1. MRS evaluation
MRS evaluation of the studied 40 patients revealed that 36
cases of the 40 patients (90%) had primary tumors and 4
patients (10%) had metastatic tumors as shown in Table 1 &
Fig. 1.
3.1.1. Calculated CHO/Cr ratios from intralesional areas
Calculated CHO/Cr ratios from the intra-lesional areas
showed significant increase from low grade to high grade
tumors with no significant difference between high grade
primary and metastases as shown in Table 2 & Fig. 2.
Table 1 The tumor groups according to the MRS evaluation.
Tumor group No. of cases (40)
1-Primary 36 (90%)
2-Metastatic 4 (10%)
X2 6.459
P. value 0.014
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Fig. 1 The tumor groups according to the MRS evaluation.
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Fig. 2 Intralesional CHO/Cr ratio among the studied cases.
Table 3 Perilesional CHO/Cr ratios among the studied cases.
Type of tumor Range Mean ±SD t. test p. value
*Primary tumor
Low grade primary 61 0.63 0.10 4.633 0.009
High grade primary 1.9–6 3.85 1.25
*Metastases 61 0.74 0.010 – –
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Differentiation of supratentorial brain tumors 10393.1.2. Calculated CHO/Cr ratios from perilesional areas
Calculated CHO/Cr ratios from the perilesional areas showed
increase in CHO/Cr ratios (>1) in primary high grade tumors
(indicating perilesional infiltration) while there was no increase
in CHO/Cr ratio (61) in cases of metastases (indicating no per-
ilesional infiltration) as shown in Table 3 & Fig. 3.0
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Fig. 3 Perilesional CHO/Cr ratio among the studied cases.
Table 4 The estimated intralesional ADC values in the
studied cases.
Type of tumor Range Mean ±SD t. test p. value
*Primary tumors
Low grade 1.2–1.6  103 mm2/
s
1.30 0.17 2.996 0.042
High grade 0.6–1.1  103 mm2/
s
0.86 0.203.1.3. Lipid & lactate levels
Low grade primary tumors showed low lactate and lipid, with
increasing malignancy, tumors showed increasing levels of lac-
tate and lipid peaks (indicating necrosis) with remarkable dif-
ference in lipid peaks between low and high grade tumors.
There was no significant difference between primary to meta-
static brain tumors as regards lactate peak.
3.2. Diffusion image evaluation
(a) Intralesional evaluation: As shown in Table 4 & Fig. 4,
the calculated ADC value could not distinguish between
primary and metastatic brain tumors but calculated
ADC values were effective in grading of malignant
tumors. High grade malignant tumors had significantly
lower ADC values than those of low grade malignant.
Intralesional ADC values calculated from Low grade
primary tumor areas were (1.2–1.6  103 mm2/s).Table 2 Intralesional CHO/Cr ratio among the studied cases.
Type of tumor Range Mean ±SD t. test p. value
*Primary tumors
Low grade tumor 1–3 1.96 0.42 2.635 0.024
High grade tumor 1.6–9.8 5.36 1.25
*Metastasis 1.4–6 4.35 1.06 - -
*Metastasis 0.6–1  103 mm2/s 0.73 0.12 – –Intralesional ADC values showed no difference between
the metastases (0.6–1  103 mm2/s) and high grade pri-
mary tumors (0.6–1.1  103 mm2/s). Table 4 & Fig. 4.
(b) Perilesional evaluation: As shown in Table 5 & Fig. 5.
The final histopathological results of 40 patients revealed 35
case primary tumors (85%) which were divided into 4
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Fig. 4 The estimated intra lesional ADC values in the studied
cases.
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Fig. 5 The estimated perilesional ADC values in the studied
cases.
Table 6 The final histopathological results of the studied
cases.
Type of tumor No. %
*Primary tumors 35 85
Low grade glioma (I-II) 13 30
Anaplastic astrocytoma (III) 3 10
Glioblastoma multiformis 17 40
Lymphoma 2 5
*Metastases 5 15
X2 3.025
P. value 0.042
1040 A.M.N. Darwiesh et al.categories ‘‘13 cases of low grade glioma (30%), 3 cases of
anaplastic astrocytoma (10%), 17 cases of glioblastoma multi-
formis (40%), 2 case of lymphoma (5%)”, and 5 cases of
metastases (15%) as shown in Table 6 & Fig. 6.
Comparison between MRI & histopathological results were
obtained postoperatively by frozen section, as shown in Table 7
& Fig. 7.
4. Discussion
Conventional magnetic resonance imaging is still the basic
imaging requirement for initial evaluation of brain tumors. It
gives basic information about anatomical features of these
tumors such as edema, mass effect, pattern of enhancement
(9). MRS limits the use of invasive diagnostic approaches such
as brain biopsy, as histopathology is the gold standard for
diagnosis of brain tumors (10). In contrast to the structural
information provided by MRI, MRS provides a qualitative
analysis of a number of metabolites within the brain. These
metabolites reflect aspects of neuronal integrity, cell membrane
proliferation or degradation, energy metabolism and necrotic
transformation of brain or tumor tissue (11). Our MRS results
showed that all of them showed variable degrees of increased
CHO peak and CHO/NAA ratios using long TE (144 m sec)
with significant increase from low grade and high grade tumor
without any significant difference between primary and meta-
static brain tumors. This agreed with result of Martinez-Bisal
and Celda (12) and Shokry (9) that increase in CHO/NAA
ratio in lesion could only differentiate low grade primary
tumors from high grade primary tumors. A decreased Cr peak
was also detected in all cases with significant increase from low
grade to high grade tumor but without significant difference
between primary and metastatic brain tumors and this also
agreed with result of Delorme and Weber (13). While in
the short (TE 35 m s), the lactate levels showed significant
difference between low grade and high grade tumors also with-Table 5 The estimated perilesional ADC values in the studied
cases.
Type of tumor Range Mean ±SD t.
test
p.
value
*Primary tumors
Low grade 0.9–1.2  103 mm2/s 1.10 0.10 3.63 0.024
High grade 0.9–1.1  103 mm2/s 0.95 0.33
*Metastases 1.3–1.6  103 mm2/s 1.41 0.09 – –out any significant difference between primary and metastatic
brain tumors. This agreed with result of Van der Graaf (14)
who stated that the presence of the lactate peaks was usually
consistent with aggressive tumors, reflecting increased anaero-
bic metabolism and cellular necrosis and this pathology don’t
differ a lot from primary to metastatic brain tumors. However,
short (TE 35 m s), showed the higher lipid peaks in metastatic
brain tumors and showed significant difference levels from pri-
mary lesions. This agreed with Shokry (9), Opstad et al. (15) &
Van der Graaf (14) who gave a possible explanation for the
elevated lipids in metastatic lesions as the cancer cells of differ-
ent origin, contain mobile spectroscopically detectable lipids in
their cell membrane. In this study there was another important
result; intralesional voxels in primary tumors have also showed
different levels of CHO/Cr ratios which showed increase in
CHO/Cr ratios with the increase in the grade of the tumor.
So CHO/Cr ratios have shown consistency in predicting the
tumor grade, and the comparison of CHO/Cr ratios in high
grade tumors with that of low grade tumors proved a signifi-
cant difference between two groups. Chen et al. (16) and Faria
et al. (17) added that the increase in CHO/Cr ratios in high
grade tumors than those found in low grade tumors was signif-
icantly correlated with the expression of proliferating cells.
This result showed increase in perilesional CHO/Cr ratio in
high grade primary tumors with significant level differences
from metastatic brain tumors which did not show increase in
perilesional CHO/Cr ratio. This agreed with Opstad et al.
(15) & Faria et al. (17) result and they added that primary high
grade tumors have been reported to have peritumoral infiltrat-
ing neoplastic cells. So perilesional edema showed spectro-
scopic malignant changes in the form of higher CHO/Cr
ratio in primary tumors than metastatic, and this matched
agreement with Shokry (9).
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Fig. 6 The final histopathological results of the studied cases.
Table 7 Comparison between MRI and histopathological results.
cMRI MRI/MRS/DWI Histopathology cMRI& Histopathology MRI/MRS/DWI& Histopathology
X2 P X2 P
*Primary tumors 35 (87%)
Low grade 30 (75%) 36 (90%) 13 (32.5%) 1.54 0.07 1.96 0.03
High grade 12 (30%) 16 (44.5%) 17 (42.5%) 0.96 0.14 2.36 0.01
Astrocytoma 18 (45%) 20 (55.5%) 3 (7.5%) 1.13 0.24 3.41 0.03
Lymphoma 2 (5%)
*Metastasis 3 (7.5%) 4 (10%) 5 (13%) 1.60 0.08 1.33 0.05
*Primary versus metastases 7 (17.5%) 0 (0%) 0 (0%) 0.85 0.24 – –
Total 40 40 40
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Fig. 7 Comparison between MRI and histopathological results.
Differentiation of supratentorial brain tumors 1041This result showed no significant difference in intralesional
ADC values between primary and metastatic brain tumors and
so failed to differentiate primary tumors from metastatic brain
tumors by intralesional ADC values only. This result matched
with Pavlisa et al. (18) & Ja Lee et al. (19) & Ohba et al. (20)
which referred this result due to the increase in the cellularity
of all these lesions to the level that DWI could not differenti-
ate, but this results mismatched with Chiang et al. (3) that
found that ADC values in the tumoral regions of metastasis
were significantly higher than primary tumors, but his studywas done using 3 T MR unit. Another valuable result was that
intralesional ADC values were higher in low grade primary
than high grade tumors with significant different ADC values
(1.2–1.6  103 mm2/s) for low grade tumors and (0.6–
1  103 mm2/s) for high grade tumors. So in our study it
could be able to differentiate low grade tumors from high
grade tumors using ADC values, and this agreed with the
result of Ohba et al. (20) who added that ADC values can
be used to grade primary tumors. Also we found that perile-
sional ADC values were higher in metastatic brain tumors
1042 A.M.N. Darwiesh et al.than primary high grade tumors with significant ADC value
changes between both. Perilesional ADC values calculated
around tumor areas were higher in metastasis (vasogenic
edema) denoting no perilesional infiltration (1.3–
1.6  103 mm2/s) than high grade primary tumors (0.9–
1.1  103 mm2/s) denoting peri lesion infiltration. So in the
current study it could be able to differentiate primary from
metastatic brain tumors which means high sensitivity of
ADC values to differentiate between primary and metastatic
brain tumors. This matched with the result of Faria et al.
(17) who referred this result to perilesional infiltration of pri-
mary high grade tumors which increase cellularity in perile-
sional area while metastatic cases show no perilesional
infiltration raising ADC values in perilesional edema. In our
study, ADC values calculated from primary tumoral area
had the lowest values in high-grade malignant tumors. We
could not find any difference among the ADCs of the tumor
types in the same grade.
5. Conclusion
From the current study it can be concluded that the combina-
tion of MR spectroscopy and DWI with ADC values calcula-
tion could improve the diagnostic efficacy of MR imaging in
the diagnosis and grading of malignant brain tumors. Intra-
lesional ADC values are not useful in the differentiation
between primary and metastatic tumors with no valuable
changes. Perilesional ADC values can differentiate between
primary & metastatic brain tumors.
MRS may enable differentiation between lesions showing
similar aspects on conventional MRI. Choline is considered
the most specific marker of intracranial neoplasm. Increase
in Choline levels and Choline/NAA ratios are very suggestive
of the malignant nature of the neoplasm, its grading and its
follow-up to evaluate the response of the treatment.
Conﬂict of interest
The authors declare that they have no conflict of interest.
References
(1) Tilgner J, Herr M, Ostertag C, Volk B. Validation of intraoper-
ative diagnoses using smear preparations from stereotactic brain
biopsies; intraoperative versus final diagnosis – influence of
clinical factors. Neurosurgery 2005;56.
(2) Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Ucoz T. Combi-
nation of single-voxel proton MR spectroscopy and apparent
diffusion coefficient calculation in the evaluation of common
brain tumors. Am J Neuroradiol 2003;24:225–33.
(3) Chiang IC, Kuo YT, Lu CY, Yeung KW, Lin WC, Sheu FO,
et al. Distinction between high-grade gliomas and solitarymetastases using peritumoral 3-T magnetic resonance spec-
troscopy, diffusion, and perfusion imaging. Neuroradiology
2004;46:619–27.
(4) Smith JK, Castillo M, Kwock L. MR spectroscopy of brain
tumors. Magn Reson Imag Clin North Am 2003;11:415–29.
(5) Dawoud MA, Sherif MF, Eltomy MA. Apparent diffusion
coefficient and magnetic resonance spectroscopy in grading of
malignant brain neoplasms. EJRN 2014;45:1215–22.
(6) Dorenbeck U, Butz B, Schlaier J, Schuierer G, Feuerbach S.
Diffusion-weighted echo-planar MRI of the brain with calculated
ADCs: a useful tool in the differential diagnosis of tumor necrosis
from abscess? J Neuroimag 2003;13:330–8.
(7) Yamasaki F, Kurisu K, Satoh K. Apparent diffusion coefficient
of human brain tumors at MR imaging. Radiology
2005;235:985–99.
(8) Howe FA, Barton SJ, Cudlip SA. Metabolic profiles of human
brain tumors using quantitative in vivo H-1 magnetic resonance
spectroscopy. Magn Reson Med 2003;49(2):223–32.
(9) Shokry A. MRS of brain tumors: diagrammatic representations
and diagnostic approach. Egypt J Radiol Nucl Med 2012;43
(4):603–12.
(10) Burger PC, Scheithauer BW, Paulus W. Pilocytic astrocytoma. In:
Kleihues P, Cavenee WK, editors. Pathology and genetics of
tumours of the nervous system. Lyon, France: International
Agency for Research on Cancer; 2000. p. 45–51.
(11) Sibtain NA, Howe FA, Saunders DE. The clinical value of proton
magnetic resonance spectroscopy in adult brain tumors. Clin
Radiol 2007;62:109–19.
(12) Martinez MC, Celda B. Proton MR spectroscopy imaging in the
study of human cancer. J Nucl Med Mol Imag 2009;53:618–30.
(13) Delorme S, Weber M. Applications of MRS in the evaluation of
focal malignant brain lesions. Cancer imag 2006;6:95–9.
(14) Van Der Graaf M. In vivo magnetic resonance spectroscopy:
basic methodology and clinical applications. Eur Biophys J
2010;39(4):527–40.
(15) Opstad KS, Murphy MM, Wilkins PR. Differentiation of
metastases from high-grade gliomas using short echo time 1H
spectroscopy. J Magn Reson Imag 2004;20:187–92.
(16) Chen J, Huang SL, Li T. In vivo research in astrocytoma cell
proliferation with proton magnetic resonance spectroscopy:
correlation with histopathology and immunohistochemistry.
Neuroradiology 2006;48(5):312–8.
(17) Faria AV, Macedo FC, Marsaioli AJ. Classification of brain
tumor extracts by high resolution 1H MRS using partial least
squares discriminate analysis. Braz J Med Biol
2011;44:1678–4510.
(18) Pavlisa G, Rodos M, Gordana P. The differences of water
diffusion between brain tissue infiltrated by tumor and peritu-
moral vasogenic odeama. Clin Imag 2009;33:96–101.
(19) Ja Lee E, TerBrugge K, Choil DS. Diagnostic value of peritu-
moral minimum apparent diffusion coefficient for differentiation
between glioblastoma multiforme from solitary metastatic lesions.
Am J Radiol 2011;196:71–6.
(20) Ohba S, Ushioda T, Nakagawa T. Diffusion magnetic resonance
imaging for enhanced visualization of malignant cerebral tumors
and abscesses. Neurol India 2011;59:674–8.
